Correlation Between BioSig Technologies, and Nemaura Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioSig Technologies, and Nemaura Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioSig Technologies, and Nemaura Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioSig Technologies, Common and Nemaura Medical, you can compare the effects of market volatilities on BioSig Technologies, and Nemaura Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioSig Technologies, with a short position of Nemaura Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioSig Technologies, and Nemaura Medical.

Diversification Opportunities for BioSig Technologies, and Nemaura Medical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioSig and Nemaura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioSig Technologies, Common and Nemaura Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nemaura Medical and BioSig Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioSig Technologies, Common are associated (or correlated) with Nemaura Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nemaura Medical has no effect on the direction of BioSig Technologies, i.e., BioSig Technologies, and Nemaura Medical go up and down completely randomly.

Pair Corralation between BioSig Technologies, and Nemaura Medical

If you would invest  93.00  in Nemaura Medical on November 3, 2024 and sell it today you would earn a total of  0.00  from holding Nemaura Medical or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.0%
ValuesDaily Returns

BioSig Technologies, Common  vs.  Nemaura Medical

 Performance 
       Timeline  
BioSig Technologies, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioSig Technologies, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Nemaura Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nemaura Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Nemaura Medical is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

BioSig Technologies, and Nemaura Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioSig Technologies, and Nemaura Medical

The main advantage of trading using opposite BioSig Technologies, and Nemaura Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioSig Technologies, position performs unexpectedly, Nemaura Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nemaura Medical will offset losses from the drop in Nemaura Medical's long position.
The idea behind BioSig Technologies, Common and Nemaura Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios